VIM and lung cancer: The newly discovered coronavirus, SARS-CoV-2, can induce EMT-like changes via upregulation of ZEB1 and AXL in lung cancer cells [162]; vimentin is reported to be the prerequisite for the viral entry into the cell by acting as a co-receptor [163].